Are Preoperative Systemic Immune Index and Neutrophil-to-Lymphocyte Ratio Sufficient to Predict Lymph Node Positivity and Overall Survival in Muscle-Invasive Bladder Cancer Cases?
- 1 September 2021
- journal article
- research article
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 59 (4), 335-339
- https://doi.org/10.4274/haseki.galenos.2021.7396
Abstract
Aim: The neutrophil-lymphocyte ratio (NLR) is a parameter that has been shown to be effective as a prognostic marker in many solid tumors. It is aimed to investigate NLR and the systemic immune-inflammation index (SII) in predicting the overall survival and lymph node positivity in bladder cancer (BC). Methods: The retrospective study included patients that underwent radical cystoprostatectomy/radical cystectomy (RC) due to muscle-invasive bladder cancer (MIBC), high-grade T1 BC, or carcinoma in situ in our clinic between January 2010 and March 2020. All the patients had no history of preoperative metastasis, lymph nodes, chemotherapy, hematological malignancies, and preoperative urinary tract infection. Data on neutrophil, lymphocyte, platelet, and hemoglobin levels and total white blood cell counts were retrieved from clinical records and data on disease stage and lymph node positivity were retrieved from pathology reports. Follow-up times and survival times were recorded. Results: The 213 patients comprised 196 (92%) men and 17 (8%) women with a mean age of 63.17 +/- 11.25 years. Lymph node positivity was detected in 49 (23%) patients. The mean overall survival time was 75.04, 63.77, and 84.4 months in all patients, patients with lymph node positivity, and patients with lymph node negativity, respectively. No significant difference was found between patients with lymph node positivity and negativity with regard to NLR and SII values (p=0.975 and p=0.745, respectively). In the receiver operating characteristics (ROC) analysis NLR and SII had no significant effect in predicting lymph node positivity [Area under the ROC curve (AUC) 0.499 (95% confidence interval (CI): 0.403-0.594) and AUC 0.485 (95% CI: 0.394-0.575), respectively] and in predicting overall survival [AUC 0.423 (95% CI: 0.346-0.501, p=0.056) and AUC 0.435 (95% CI: 0.357-0.514, p=0.107), respectively]. Conclusion: The results indicated that SII and NLR are not sufficient to predict lymph node positivity and survival in patients with organ-confined BC.Keywords
This publication has 14 references indexed in Scilit:
- Nomogram Based on Systemic Immune-Inflammation Index to Predict Overall Survival in Gastric Cancer PatientsDisease Markers, 2018
- Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018European Urology, 2018
- The systemic immune-inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumorJournal of Translational Medicine, 2018
- Preoperative C-reactive protein/albumin ratio is a significant predictor of survival in bladder cancer patients after radical cystectomy: a retrospective studyCancer Management and Research, 2018
- Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective studyBMC Cancer, 2017
- Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched AnalysisScientific Reports, 2016
- The Clinical Use of the Neutrophil to Lymphocyte Ratio (NLR) in Urothelial Cancer: A Systematic ReviewClinical Genitourinary Cancer, 2016
- Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5European Journal of Cancer, 2015
- Bladder cancer invasion predictability based on preoperative neutrophil–lymphocyte ratioTumor Biology, 2014
- Hallmarks of Cancer: The Next GenerationCell, 2011